On June 9, 2022, DxTerity Diagnostics announced the commercial launch of its new IFN-1 Test. Type-1 Interferon (IFN-1) is a key lupus biomarker, a measure of lupus disease severity. IFN-1 status may ...

An international group of lupus researchers have developed a new measurement tool to assess brain fog and cognitive symptoms ...

This test had 86% accuracy for distinguishing active lupus nephritis from all other lupus patients. Utilizing the ALCAM biomarkers discovered by Mohan, Richard Willson, Huffington-Woestemeyer ...

Adults with lupus skin symptoms are being recruited for Phase 3 trials in the U.S. and Canada to test the experimental oral ...

Renal function testing is underused to diagnose and manage lupus nephritis. Appropriate testing may help reduce disease progression and the associated worsening of outcomes. Investigators analysed ...

New immune index supports earlier identification of patients at risk for lupus before clinical diagnosis, supporting earlier intervention and improved outcomes OKLAHOMA CITY, April 9, 2026 /PRNewswire ...

Timely diagnosis of systemic lupus erythematosus (SLE) is of critical clinical importance because it allows for an early start to treatment, preventing organ damage and improving the patient’s quality ...

Improvement in results on a noninvasive urinary biomarker panel at 3 months among patients with lupus nephritis predicted a clinical response at 1 year. A noninvasive urinary biomarker panel predicts ...

Imagine your body attacking itself. That’s what happens with lupus, a chronic autoimmune disease affecting millions worldwide. Lupus Alert Day is a chance to shine a spotlight on this condition. It’s ...

Early diagnosis of lupus is important, so that treatment to prevent irreversible organ damage can begin. In this national registry study, lupus diagnosis was preceded by years of markedly increased ...